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ABSTRACT
The polymicrobial nature of most infections is often characterized by complex biofilm commun-
ities, where pathogen interactions promote infection progression and severity. Quorum-sensing,
the major regulator of virulence and inter-species communication, is a promising target for new
anti-infective strategies. This study aimed at collecting and analysing experimental information
on the molecular basis of Pseudomonas aeruginosa and Staphylococcus aureus interactions in bio-
films. Data were systematically annotated from relevant full-text papers optimally retrieved from
PubMed, reconstructed as networks and integrated with specialized databases to identify promis-
ing antimicrobial targets. Network analysis revealed key entities regulating P. aeruginosa/S. aureus
interactions, for instance the PqsABCDE/PqsR quorum-sensing system, which affects S. aureus
growth and biofilm formation. By identifying the most reported P. aeruginosa virulence factors
affecting S. aureus, for example, HQNO and siderophores, a list of experimentally validated
agents affecting those factors, ranging from synthetic drugs to natural plant extracts, was con-
structed. The complex experimental data on P. aeruginosa/S. aureus interactions were for the first
time systematically organized and made publically available in the new Inter-Species CrossTalk
Database (www.ceb.uminho.pt/ISCTD).
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Introduction
Despite important advances in its research, biofilms
remain a critical concern for many biomedical applica-
tions, being responsible for approximately 80% of
human bacterial infections, such as those associated
with the implant of medical devices and chronic infec-
tions, for example, lung infections, wounds, among
others (Fey 2010; Jorge et al. 2012).
Within the biofilm context, Pseudomonas aeruginosa
and Staphylococcus aureus are frequently coexisting
pathogens, responsible for co-colonization and co-
infection in predisposed patients (Hoffman et al. 2006).
The success of these infections is greatly due to their
individual pathogenicity emanating from their meta-
bolic versatility (Frimmersdorf et al. 2010), intrinsic and
acquired antibiotic resistance (Schmidtchen et al. 2001),
biofilm formation (Costerton 2001), and production of
multiple virulence factors (Archer et al. 2011;
Balasubramanian et al. 2013). Quorum sensing (QS)
plays a major role in regulating all these individual
traits, but it also controls inter-species communication,
phenomenon that often leads to the progression and
exacerbation of infection, usually ending in a worse dis-
ease prognosis (Castillo-Juarez et al. 2015; Jennings
et al. 2017; Sobin et al. 2017).
P. aeruginosa and S. aureus pathogenicity
P. aeruginosa is a well-known Gram-negative opportun-
istic human pathogen capable of causing both acute
and chronic infections, being highly related to nosoco-
mial infections (Sharma et al. 2014). The lungs are one
of the most relevant niches for P. aeruginosa coloniza-
tion, making it one of the most common pathogens iso-
lated from respiratory infections, such as cystic fibrosis
(CF) lung infection (Folkesson et al. 2012; Rodrigo-
Troyano and Sibila 2017). Moreover, its great adaptabil-
ity, phenotypic and genomic plasticity, ubiquity, and
opportunistic sense (Shen et al. 2006; Silby et al. 2011;
Brown et al. 2012) enables P. aeruginosa association
with other types of infection, such as burns, wounds
(Mulcahy et al. 2014; Turner et al. 2014), and those asso-
ciated with biomaterials (Breidenstein et al. 2011).
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To aggravate this scenario, multidrug-resistant (MDR)
P. aeruginosa strains are emerging with increasing fre-
quency, rendering ineffective many of the existing anti-
biotic treatments (Chopra et al. 2008; Boucher et al.
2009). In fact, the World Health Organization (WHO) has
recently identified carbapenem-resistant P. aeruginosa
as a critical threat for which there is an urgent need for
new therapies (WHO 2017a). P. aeruginosa displays
intrinsic resistance to different types of antibiotics, for
example, aminoglycosides, quinolones, and b-lactams,
due to resistance mechanisms such as low outer mem-
brane permeability, multi-drug efflux systems, and inac-
tivating enzymes (e.g. b-lactamase) (Pang et al. 2019). P.
aeruginosa can also acquire resistance genes from other
microorganisms by horizontal gene transfer, while also
being able to experience adaptive resistance, as is the
case of biofilm formation (Jorge et al. 2019).
The long persistence of P. aeruginosa infections
seems to be related with complex mechanisms of adap-
tation in which virulence factors are expressed accord-
ing to the infection stage. Several factors have been
accounted for the pathogenic potential of this bacter-
ium, with many playing a role in its biofilm formation
and dispersal. Such factors include those related with
motility (e.g. flagella, pili) (Kazmierczak et al. 2015),
enzymes (e.g. proteases) (Lee and Zhang 2015), sidero-
phores (pyoverdine and pyochelin) (Reinhart and
Oglesby-Sherrouse 2016), surfactants (e.g. rhamnolipids)
(Solano et al. 2014), toxins (e.g. exotoxin A, pyocyanin)
(Michalska and Wolf 2015; Hall et al. 2016), and the
type-3 secretion system (T3SS) (Hauser 2009).
S. aureus is a Gram-positive human commensal bac-
teria frequently found in the mucosal surfaces of the
nose and respiratory tract, and on the skin (Wendlandt
et al. 2013; Lister and Horswill 2014). Consequently, it is
easily transmitted by direct contact, making most of the
population prone to infection. In the United States of
America, a large part of healthy individuals are colon-
ised with S. aureus (30–50%), within which 1% are
colonized with methicillin-resistant S. aureus (MRSA)
(Bhattacharya et al. 2015). Because of this, S. aureus is
very often associated with nosocomial infections, since
it is commonly transmitted by colonised healthcare
staff through direct contact or invasive medical proce-
dures (Bhattacharya et al. 2015). Its ability to evolve and
adapt to multiple settings has led MRSA to rapid dis-
perse over the globe, being considered a high threat
according to the WHO (WHO 2017b; Jorge et al. 2019).
Additionally, MRSA has been developing resistance to
virtually all antibiotics classes that are used to treat it,
either by making use of its intrinsic resistance factors or
by acquiring more through mutations or horizontal
gene transfer from other microorganisms (Watkins
et al. 2019).
Biofilms of S. aureus are related to many serious
acute and chronic infections whose treatment can be
complicated since many of its clinical isolates are either
MRSA or MDR (Archer et al. 2011; Nair et al. 2014).
Furthermore, it has been reported that the presence of
S. aureus in heterogeneous biofilms increases the rate
of plasmid horizontal transfer, which increases the anti-
biotic resistance of the biofilm (Venkatesan et al. 2015).
The ability of S. aureus to survive host immune defences
and cause a diverse range of diseases has been attrib-
uted to the expression of a broad set of virulence fac-
tors (Kong et al. 2016). For example, cell wall-anchored
proteins (e.g. clumping factors, fibronectin proteins,
protein A, and collagen adhesin) enable tissue attach-
ment and evasion of the host immune system, allowing
biofilm formation (Foster et al. 2014). Extracellular tox-
ins (e.g. haemolysin, leukotoxin, exfoliative toxin,
enterotoxin, and toxic-shock syndrome toxin-1) and
enzymes (e.g. coagulase, proteases, and staphylokinase)
are secreted to help in tissue penetration and host inva-
sion (Kong et al. 2016). Surface-associated factors are
down-regulated and surfactants are expressed in later
stages leading to biofilm dispersion and infection
spreading (Lister and Horswill 2014). The phenotype of
small colony variants (SCV) in S. aureus has also been
linked to infection persistence, as they seem to be able
to establish intracellular infection and have a reduced
metabolic state, thus lowering antibiotic efficacy (Garcia
et al. 2013; Proctor et al. 2014). SCV also stimulate a
reduced immune response and express increased adhe-
sins and reduced toxins (Tuchscherr et al. 2010).
P. aeruginosa and S. aureus quorum
sensing regulation
QS is a communication mechanism that regulates gene
expression in response to fluctuations in cell-population
density (Waters and Bassler 2005). In QS, bacteria pro-
duce signal molecules, termed auto-inducers (AI),
whose concentration increases as a function of cell
density (Dixon and Hall 2015). Alterations in gene
expression occur when the concentration of an AI
reaches a minimal threshold (Hawver et al. 2016).
Usually, AI regulate genes encoding virulence factors,
such as those involved in biofilm formation and
enhanced motility, but they can also coordinate interac-
tions between microorganisms (intra- and inter-species)
and between the microorganism and the host (Knecht
et al. 2016; Grandclement et al. 2016).
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Four main QS systems have been identified in P. aeru-
ginosa (Figure 1), namely the LasI/LasR and the RhlI/RhlR
systems (Pesci et al. 1997), the PqsABCDE/PqsR
system (Dubern and Diggle 2008), and the AmbBCDE/
IqsR system (Lee et al. 2013). Each system has
a corresponding AI: 3-oxododecanoyl-L-homoserine
lactone (3-oxo-C12-HSL), N-butanoyl homoserine lactone
(C4-HSL), 2-heptyl-3-hydroxy-4-quinolone (Pseudomonas
Quinolone Signal - PQS), and 2-(2-hydroxyphenyl)-
thiazole-4-carbaldehyde (Integrated Quorum Sensing
Signal - IQS), respectively (Lee and Zhang 2015). The QS
systems regulate the expression of various genes related
with motility, biofilm formation, immune evasion, iron
scavenging, and antibiotic resistance (Jakobsen et al.
2013), as well as each other, in a hierarchical manner
(Figure 1).
The virulence factors expressed by P. aeruginosa are
diversified and several of them play a role in the pro-
cess of biofilm development (Perez-Perez et al. 2017).
For example, the PqsABCDE/PqsR system is responsible
for extracellular DNA (eDNA) and lectin production,
which are related to biofilm formation and structural
stability (Allesen-Holm et al. 2006; Lee and Zhang
2015). In addition, the RhlI/RhlR system controls the
expression of rhamnolipids that influence the late stage
of biofilm formation and its dispersal (Davey et al. 2003;
Lequette and Greenberg 2005). The latter phenomenon
is also controlled by the LasI/LasR system by downregu-
lation the expression of PEL, a major biofilm matrix
component (Ueda and Wood 2009). QS also influences
swarming motility, which has been linked to early
stages of biofilm formation (Shrout et al. 2006) and
is also related to the antibiotic tolerance found in
P. aeruginosa biofilms but not in planktonic cells (Ciofu
et al. 2015; Jorge et al. 2019).
As regards to QS in S. aureus, this bacterium deploys a
wide collection of virulence factors in order to establish
and sustain infection that are primarily coordinated by a
complex global regulatory QS system known as accessory
gene regulator (Agr). This QS system encodes a signalling
circuit that produces and senses the extracellular AI auto-
inducing peptide (AIP) and the intracellular effector
RNAIII (Figure 1) (Recsei et al. 1986; Le and Otto 2015),
being responsible for inducing the expression of toxins,
which include haemolysins, phenol-soluble modulins
(PSM), toxic shock syndrome toxin (TSST), enterotoxins,
and Panton-Valentine leukocidin (PVL), among others
(Otto 2014; Cheung et al. 2014; Fisher et al. 2018). Apart
from toxins, the secretion of several S. aureus enzymes,
such as proteases, staphylokinase (SAK), and lipases, has
been related to the Agr system (Le and Otto 2015;
Pietrocola et al. 2017). Biofilm formation has also been
strongly associated with Agr function, with
downregulation leading to excessive biofilm thickness
and lack of structuring, and upregulation inducing biofilm
dispersal (Vuong et al. 2000, 2004; Cheung et al. 2011),
indicating that the absence of Agr functionality may be
advantageous for the success of persistent S. aureus infec-
tions (Goerke et al. 2000; Otto 2014). Also, the emergence
of SCV, strongly associated with chronic and recurrent
infections and lack of ability to produce cytolytic toxins, is
due to reduced Agr activity and disrupted electron trans-
port chain (Tuchscherr et al. 2011; Pader et al. 2014).
A second QS system, closely related to Agr, is the
TRAP/RAP system. The RNAIII-activating peptide (RAP) is
an AI that causes phosphorylation of its target protein
(TRAP). TRAP is responsible for inducing the production
of adhesion proteins, stimulating biofilm formation, and
also activates the Agr system. The TRAP/RAP system is
mainly active during the early/mid exponential growth
phase and it is followed by the Agr system, which is
mainly active during the mid/late exponential growth
phase (Ciulla et al. 2019). In addition to these two QS
systems, other regulatory systems, namely the staphylo-
coccal accessory regulator (SarA), the S. aureus exopro-
tein (Sae) operon, and the staphylococcal alternative
sigma factor B (SigB), regulate the production of viru-
lence factors and intervene in S. aureus biofilm forma-
tion (Zielinska et al. 2012; Le and Otto 2015; Liu
et al. 2016).
P. aeruginosa and S. aureus in polymicrobial
biofilm infections
P. aeruginosa and S. aureus co-occur in many biofilm-
related infections and the relation between them is
known to be competitive in nature (Nair et al. 2014). P.
aeruginosa can inhibit the growth and even kill S. aur-
eus when present in close proximity due to the produc-
tion of several toxins, such as pyocyanin, hydrogen
cyanide, and alkyl-hydroxyquinoline N-oxides, which
can block the electron transport chain of S. aureus.
Accordingly, these toxins also mediate the spatial seg-
regation between the two species (Nair et al. 2014;
Stacy et al. 2016). Despite this competition, S. aureus
usually persists in P. aeruginosa infections, which might
be related to the restriction of cell migration in P.
aeruginosa highly viscous biofilms (Alves et al. 2018).
Also, in biofilms where segregation between the two
species is not complete, non-resistant S. aureus can
benefit from being surrounded by resistant P.
aeruginosa cells (Nair et al. 2014; Stacy et al. 2016).
Lastly, S. aureus can employ mechanisms to counteract
the effect of P. aeruginosa toxins, such as the formation
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Figure 1. QS regulation in P. aeruginosa and S. aureus. (A) Hierarchical regulation of the four QS systems in P. aeruginosa. At the
top of the hierarchy is the LasI/LasR system, which, when activated by 3-oxo-C12-HSL, upregulates itself (positive feedback loop)
and the other three QS systems. The RhlrI/RhlR system also upregulates itself and downregulates the PqsABCDE/PqsR system.
The latter also has a positive feedback loop and upregulates the RhlrI/RhlR system. It is noteworthy that this system is respon-
sible for the synthesis of 2-alkyl-4-quinolones, namely PQS, HHQ, and HQNO, which are known to influence P. aeruginosa/S. aur-
eus interactions. Finally, the more recently described AmbBCDE/IqsR system upregulates the RhlrI/RhlR system. (B) S. aureus Agr
and TRAP/RAP regulatory systems. The agr operon consists of two transcriptional units, RNAII and RNAIII, driven by the promoters
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of SCV (Nair et al. 2014). All these factors increase the
antimicrobial resistance of the polymicrobial biofilm
and enhance the severity of the related infection.
Despite new insights into the complexity and impact
of multi-species infections on human health, the impact
of polymicrobial interactions on infectious diseases
remains challenging to examine in laboratory context
(Lyczak et al. 2002; Rogers et al. 2010; Price et al. 2013;
Filkins et al. 2015). The gap is centred on the dearth of
appropriate in vitro models that accurately reproduce the
host environments, particularly the availability of required
nutrients and the impact of host immune factors.
This manuscript discusses various aspects of the social
behaviour of P. aeruginosa and S. aureus interactions in
infectious diseases, according to experimental findings
reported in scientific literature. The main goals are to map
the mechanisms underlying those interactions, through
the collection and curation of scientific textual evidences,
in order to gain insight into the implications that P. aeru-
ginosa and S. aureus interactions have on the progression
and outcome of polymicrobial infections, and analyse this
information to pinpoint critical communication channels
to be explored for antimicrobial therapy. Therefore, the
main contributions of this work are the reconstruction of
a knowledge network of up-to-date experimental results
on this subject, the deposition of the gathered data in a
newly constructed and publicly accessible database
(www.ceb.uminho.pt/ISCTD), and the identification of
promising therapeutic targets for P. aeruginosa/S. aureus
co-infections and their respective reported inhibitors.
Materials and methods
This section describes the steps followed to obtain and
curate the information on P. aeruginosa and S. aureus
communication. Moreover, it presents the bioinformat-
ics tools available to explore the gathered data.
Information retrieval and annotation
The information needed to reconstruct the P. aeruginosa/
S. aureus communication network was retrieved from
PubMed (Sayers et al. 2019), with emphasis put on the
compilation of experimentally validated interactions
between the two species. PubMed queries were opti-
mised in terms of number of hits (too low: relevant papers
were missed; too high: too many irrelevant papers and
impracticable annotation effort) and scope, which was
narrowed to experiments mentioning the names of the
two species and common terminology denoting simultan-
eous culturing (e.g. co-cultivation, co-infection, co-culture,
polymicrobial, multispecies, mixed-biofilm, etc.). This
ensured that PubMed results encompassed almost all the
body of work in the field. Subsequently, the relevance of
each retrieved document was assessed and relevant infor-
mation (e.g. textual mentions to organisms, strains, mode
of growth, interaction outcome, diseases, and experimen-
tal methods) was annotated from the full-text documents.
The entity and interaction categories used in expert anno-
tation are described in Tables 1 and 2, respectively.
Information representation and integration
The network analysis software Cytoscape (Shannon
et al. 2003) was used to represent the gathered data in
network format. All the curated data was made publicly
available in the newly constructed Inter Species
CrossTalk Database (ISCTD), the first database solely
focussed on microorganism communication, at www.
ceb.uminho.pt/ISCTD. All data were transformed into
JSON format and the online database constructed using
Visual Studio software and HTML, CSS, JavaScript, and
jQuery programming languages. Textual evidences
were integrated with pertinent regulatory data in the
literature for P. aeruginosa. Data on anti-QS agents
experimentally validated for P. aeruginosa was retrieved
from the PCQuorum database (Perez-Perez et al. 2017)
and integrated with the new gathered data.
Results and discussion
Database and knowledge network overview
The gathered data stemmed from an annotation effort
that resulted in the reconstruction of a network com-
prehending a total of 670 interactions between
P2 and P3, respectively. RNAII is a four gene operon, agr BDCA, encoding AgrB responsible for processing and exporting AgrD,
the AIP precursor. AIP is an exclusively extracellular AI produced in the mid exponential growth phase, whose threshold levels
cause AgrC to autophosphorylate, leading to the phosphorylation of AgrA. AgrA activates RNAIII expression, an intracellular
effector responsible for increasing the secretion of S. aureus toxins and enzymes. In turn, RAP (RNAIII-activating peptide) is
another S. aureus AI that, in the initial exponential growth phase, induces the phosphorylation of TRAP, its target protein and
master regulator of S. aureus pathogenesis, activating it. This causes the passage from the planktonic to the biofilm mode of
growth and the activation of the Agr system. The two QS systems are therefore connected and are phase-dependent, with AIP
indirectly downregulating TRAP phosphorylation. Solid arrows: upregulation of gene expression; dashed arrows: gene expression;
dotted arrows: synthesis process; lines with flat ends: downregulation of gene expression; double solid arrows: receptor agonism;
double dashed arrows: activation process.
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P. aeruginosa and S. aureus described in 61 different
scientific publications (dating from 1993 until October
2019). The annotated information on P. aeruginosa/S.
aureus interactions was made publicly accessible at
www.ceb.uminho.pt/ISCTD, in which users can perform
searches and navigate through the annotated data. As
illustrated in Figure 2, database users are allowed to do
more or less refined searches depending on their spe-
cific interests. Specifically, users may search for interac-
tions based on one or two specific entity categories
(source and target) or considering a specific interaction
direction (P. aeruginosa > S. aureus or S. aureus > P.
aeruginosa) (Figure 2(A)). The respective data table is
generated, showing an organized view of all interaction
details, such as organism strains, mode of growth,
experimental methods, observations made by the
experts, and PubMed references. Users can then narrow
down their search by querying for specific terms within
the generated table (Figure 2(B)), for example “biofilm”.
Figure 3 depicts a representation of this curated
knowledge network, illustrating the complexity and the
wide array of entities so far reported as involved in this
inter-species interaction. This complexity is also
Table 1. Annotated entity categories.
Entity Categories Examples
Cell P. aeruginosa, S. aureus
Gene pvl, pvdE, pchA
QS Molecule or AI 2-heptyl-4-hydroxy quinoline N-oxide (HQNO),
Pseudomonas Quinolone Signal (PQS)
Virulence Mechanism Biofilm, SCV
Virulence Factor Siderophores, DesB
Other Non-virulent proteins (e.g. TatC), metabolites
(e.g. acetate), cell components
(e.g. peptidoglycan), among others…
Entity and entity category were termed “cell” when the effector or target
was unspecified.
Table 2. Annotated interaction categories.
Interaction Category Description
Upregulation Increase regarding the expression of a gene/protein.
Downregulation Decrease regarding the expression of a gene/protein.
Stimulation Increase in the appearance/amount of virulence mechanisms/factors
(or other molecules) or bacterial growth/viability.
Inhibition Decrease in the appearance/amount of virulence mechanisms/factors
(or other molecules) or bacterial growth/viability.
Null effect No alteration in the expression of a gene/protein or in the appearance/amount
of virulence mechanisms/factors (or other molecules) or bacterial growth/viability.
Protection Protective effect of one bacteria onto another.
Synergism Aggravation of the co-infection’s severity/resilience in comparison with the single-species case.
Figure 2. Schematisation of the search flow available in the ISCTD. Users go through (A) a selection flow in which they can spe-
cify the interaction direction and the source and target entity categories. When hitting “Search”, the database automatically out-
puts (B) a table containing all annotated data for that search. Users can then search keywords within the table in the search
panel. In this figure, the exemplified table shows the effect of P. aeruginosa genes on S. aureus.
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demonstrated when taking into consideration the dif-
ferent types of interactions, both positive (e.g. stimula-
tion, upregulation) and negative (e.g. inhibition,
downregulation) that are established between
both bacteria.
All the annotated data is summarised in Table 3
according to interaction directionality, i.e., P.
aeruginosa> S. aureus or S. aureus> P. aeruginosa inter-
actions, and mode of growth. Interestingly, the majority
of the annotated interactions have P. aeruginosa as the
source microorganism (64%), which is corroborated by
Figure 3(A) in which it is clear that the S. aureus node
has a greater number of inward edges (interactions)
than the P. aeruginosa node. In terms of the mode of
growth used in all the analysed studies, no major differ-
ences were seen between biofilm and planktonic
growth, with 46% of studies performed on biofilms and
about 44% on planktonic bacteria. In vivo was the least
studied setting, representing only 11% of the studies,
and was mainly related to clinical studies of human
samples rather than in vivo laboratorial testing.
Looking into studies concerning a disease scenario,
the majority were CF related (Table 3). CF is a genetic
disease associated with the dysfunction of a transmem-
brane chlorine channel that causes secretion of a
viscous mucus layer on the respiratory epithelium that
facilitates microbial colonisation, with lung disease
being the major cause of reduced life expectancy and
death in these patients (Scoffone et al. 2019). Although
S. aureus is typically one of the primary microorganisms
isolated in CF lungs during early childhood, it is quickly
followed by P. aeruginosa, which progressively increases
its prevalence as patients grow older (Razvi et al. 2009;
Price et al. 2013). When reaching 18 years of age, the
most problematic microorganism for these patients is P.
aeruginosa, with 80% being colonised with this bacter-
ium (Høiby 2011), which becomes the most common
pathogen isolated from CF sputum at this stage
(Folkesson et al. 2012). The problematic of CF lung
infection is a great example of the interplay between
the two species and may explain why the majority of
the studies focus on disclosing the mechanisms
through which P. aeruginosa and S. aureus interact in
the CF lung.
Concerning the most reported effector (source) enti-
ties, most annotated interactions reported effects of
bacteria as a whole (annotated as “cell”) (Table 3),
meaning that no molecular entity was identified/tested.
Most annotated interactions, except those annotated in
in vivo studies, have genes as the top target category
Figure 3. P. aeruginosa/S. aureus interaction network. (A) Overview of all annotated interactions reported in the scientific litera-
ture; (B) Most reported interactions (annotated more than once). Solid arrows: positive interactions (e.g. upregulation, stimula-
tion); dashed arrows: negative interactions (e.g. downregulation, inhibition); dotted arrows: null effect. P. aeruginosa and S. aureus
nodes are depicted in unfilled and filled shapes, respectively; node and node label sizes are directly proportional to the number
of related (outward and inward) edges (interactions).
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(Table 3). However, this does not translate to a high
number of studies analysing gene modulation, which
comprise only 11% of the total analysed, but rather
reflects the great amount of results that more in-depth
molecular methodologies, such as microarrays and RNA
sequencing, output, each translating into an annotated
interaction. The concomitant analysis of both bacteria
grown as a dual-species biofilm demands the adapta-
tion and optimisation of methodologies typically
designed for single-species analysis. This setback can
be what is currently impairing a greater use of in-depth
methods for the analysis of P. aeruginosa and S. aureus
interactions at the molecular level.
P. aeruginosa and S. aureus biofilm network
As stated, biofilms are known to be the mode of growth
of up to 80% of human bacterial infections (Fey 2010).
Thus, although planktonic testing is practical and
informative, studies entailing biofilms do a better job at
mimicking a real-life infection scenario. The biofilm,
planktonic, and in vivo P. aeruginosa/S. aureus inter-
action networks are represented in Figure 4. Biofilms
represent the mode of growth of 52% of the total anno-
tated interactions, which is still far from ideal.
Interestingly, when looking into P. aeruginosa > S.
aureus interactions, most of them were reported in bio-
film scenarios (71%), with only 27% using planktonic
growth (Table 3). Regarding S. aureus > P. aeruginosa
interactions, planktonic was the most used mode of
growth, namely in over 80% of the annotated interac-
tions. This is also observable in Figure 4, where there is
a clear contrast between the number of edges, i.e.,
interactions, targeting each bacteria when comparing
the biofilm (Figure 4(C)) and the planktonic
(Figure 4(A)) networks. This observation illustrates a gap
in studies concerned with the effect of S. aureus on
P. aeruginosa, revealing an urgent need for more
biofilm testing in order to originate a levelled under-
standing of the bi-directional interplay of both species
within mixed consortia.
The most annotated effector entities, apart from
“cell”, for P. aeruginosa > S. aureus biofilm interactions
were HQNO, pyochelin, and pyoverdine (Table 3), as
best represented in Figure 4(D). HQNO is a major
compound produced by the pqsABCDE operon of
P. aeruginosa (Figure 1) and is described as anti-
staphylococcal molecule acting through the inhibition
of the oxidative respiration (Williams and Camara 2009).
In turn, pyoverdine and pyochelin are the two major P.
Figure 4. P. aeruginosa/S. aureus interaction networks in planktonic, biofilm, and in vivo settings. (A) All annotated interactions in
the planktonic mode of growth; (B) Most reported interactions (annotated more than once) in the planktonic mode of growth;
(C) All annotated interactions in the biofilm mode of growth; (D) Most reported interactions (annotated more than once) in the
biofilm mode of growth; (E) All annotated interactions in vivo. Solid arrows: positive interactions (e.g. upregulation, stimulation);
dashed arrows: negative interactions (e.g. downregulation, inhibition); dotted arrows: null effect. P. aeruginosa and S. aureus
nodes are depicted in unfilled and filled shapes, respectively; node and node label sizes are directly proportional to the number
of related (outward and inward) edges (interactions).
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aeruginosa siderophores, that is, iron-chelating mole-
cules, produced in iron-limited conditions (Brandel
et al. 2012) that are able to inhibit S. aureus biofilm for-
mation. In fact, it has been shown that HQNO and the
two siderophores are both required for efficient killing
of S. aureus by P. aeruginosa (Filkins et al. 2015).
In turn, in S. aureus > P. aeruginosa interactions, the
most annotated source entities, apart from “cell”, were
exoproducts and the staphylococcal protein A (Spa)
(Table 3), as best shown in Figure 4(D). Spa is a secreted
factor that not only mediates interaction with host cells
but has also been shown to bind cell surface structures
of P. aeruginosa, inhibiting two persistence-associated
behaviours of this bacterium: biofilm formation and
uptake by host immune cells (Armbruster et al. 2016).
The testing of exoproducts was actually generally used
in all scenarios and interaction directions, except for
in vivo settings. Both HQNO and staphylococcal protein
A are examples of exoproducts, but the general term
here annotated was stemmed from studies were a spe-
cific molecule was not tested but rather the cell-free
supernatant of the bacterial culture. This was an
expected feature of these studies given that inter-
species communication and QS are mainly based on
the production and excretion of molecules to the extra-
cellular media that are sensed by other cells.
As stated, gene was the most annotated target type
in all scenarios except “in vivo”. For S. aureus > P.
aeruginosa interactions, most annotated target genes in
planktonic settings related to the iron binding and trans-
port. Iron is a vital nutrient for bacterial growth but rela-
tively scarce in most infection sites, acting as a limiting
factor (Nguyen and Oglesby-Sherrouse 2015). P. aerugi-
nosa secretes exoproducts that negatively impact S. aur-
eus growth and survival causing cell death and
subsequent iron release, which can be further utilized by
P. aeruginosa for its own benefit (Mashburn et al. 2005).
The presence of S. aureus during co-culture seems to be
related with a decreased transcription of P. aeruginosa
iron regulated genes as 51% of annotated target genes
pertained to this category, with 96% of them being
downregulated, indicating that the presence of S. aureus
increases usable iron for P. aeruginosa. In biofilm set-
tings, QS-related genes, such as rhlR, pqsH, and lasI, were
one of the top annotated targets (23%). Looking at the
types of established interactions, it is not surprising that
P. aeruginosa QS genes were downregulated or
unchanged in biofilms were S. aureus was present. P. aer-
uginosa produces multiple virulence factors that contrib-
ute to the removal of S. aureus from dual-species
biofilms, with the LasI/LasR, PqsABCDE/PqsR, and RhlrI/
RhlR QS systems being the major regulators of these
factors (Lee and Zhang 2015). In fact, when P. aeruginosa
mutants lacking one or both major QS genes (lasI, rhlI,
and lasI/rhlI) were co-cultured in dual-species biofilms
with S. aureus, a less effective removal of S. aureus was
observed, suggesting that S. aureus thrives when P. aeru-
ginosa QS is inactivated (Woods et al. 2018).
As to P. aeruginosa > S. aureus interactions in plank-
tonic settings, most annotated target gene pertained to
functions related to molecule biosynthesis (35%),
mostly of purines and pyrimidines, key components of
DNA/RNA synthesis and whose production was upregu-
lated. This could point to an early state of nitrogen star-
vation in co-culture (Tognon et al. 2019). In biofilm
settings, most annotated targets were related with ion
and molecule transmembrane transport (17%) and bio-
synthesis (13%), mostly downregulated (77% and 93%,
respectively), which may contribute to a state of meta-
bolic quiescence, decrease in biofilm formation (Miller
et al. 2017), and, possibly, SCV induction.
Discerning P. aeruginosa> S. aureus
communication in biofilms
In clinical settings, biofilm infections caused conjointly by
P. aeruginosa and S. aureus are more virulent than those
caused by each independent species, and are frequently
associated with increased disease severity and chronicity
(DeLeon et al. 2014). Nevertheless, the ecological relation-
ship established between P. aeruginosa and S. aureus, in
such niche, is competitive rather than cooperative. The
effect of P. aeruginosa in S. aureus appears to be prefer-
ably studied and will be used here to showcase the com-
plexity and diversity of established interactions.
As demonstrated in Figure 5, a complex and intricate
network of regulators dictates the expression of patho-
genicity factors in P. aeruginosa, which play an important
role in its social interplay with S. aureus within the dual-
species biofilms. P. aeruginosa secretes several extracellu-
lar substances, such as hydroxy-2-alkylquinolines (PQS
and HQNO) and hydrogen cyanide, which hinder the pro-
liferation of S. aureus biofilms (Palmer et al. 2005; Biswas
et al. 2009; Filkins et al. 2015). Both PQS and HQNO are
products of the PqsABCDE/PqsR QS system, whose action
accounted for 18 of the biofilm annotated interactions in
over 5 different documents, including stimulation of S.
aureus biofilm formation and S. aureus growth inhibition
(Figure 5). In fact, out of the existing four, this QS system
was the most reported as acting, directly or indirectly,
upon S. aureus, followed by the RhlI/RhlR system. PQS is a
signalling molecule that positively regulates a subset of
QS dependent genes involved in siderophore-mediated
iron uptake and iron chelating activity in P. aeruginosa
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(Bredenbruch et al. 2006). Specifically, PQS can prompt
the expression of genes involved both in the regulation
(pvdS) and biosynthesis of pyoverdine (e.g. pvdA and
pvdE) and pyochelin (pchE) (Diggle et al. 2007). Despite
the reported inhibitory effect of pyoverdine and pyochelin
on S. aureus (Figure 5), both siderophores were found to
be involved in its protection from antibiotic treatment in
a biofilm model of CF infection (Orazi and O’Toole 2017).
In fact, the growth of S. aureus is not completely
inhibited by P. aeruginosa. S. aureus has defence mech-
anisms that help it outcompete P. aeruginosa in the
same infection, thus coexisting as a persister (Nair et al.
2014). For instance, P. aeruginosa excretes HQNO, which
activates the alternative sigma factor B in S. aureus and
alters the expression of several virulence factors, includ-
ing those that regulate adherence, invasiveness, and
persistence within host cells, and facilitates the emer-
gence of SCV (Mitchell et al. 2010). The SCV phenotype
can survive in proximity with P. aeruginosa, which
allows S. aureus persistence. The stimulation of biofilm
formation by PQS and HQNO also contributes to this
persistence, as biofilm-enclosed cells become more pro-
tected from external stresses (Fugere et al. 2014).
Although the exact regulatory mechanisms behind P.
aeruginosa/S. aureus communication in biofilms are not
fully clear, the reconstructed knowledge-networks high-
light the complexity and multi-tiered regulatory proc-
esses by which P. aeruginosa controls expression of
virulence factors that critically affect S. aureus, impact-
ing the pathogenicity of the biofilm-related infection.
Specifically, the networks revealed that P. aeruginosa
QS signalling plays an important role in this dual-
species interplay, since three QS systems, namely the
systems LasI/LasR, RhlI/RhlR and PqsABCDE/PqsR, posi-
tively regulate the expression of specific P. aeruginosa
virulence factors affecting S. aureus.
Besides QS, the integrated regulatory network of P.
aeruginosa shows that other genes can also play key
roles and control multiple pathways that trigger inter-
species interactions. For example, PtxR is a transcrip-
tional regulator that reduces the expression of the
pqsABCDE operon (Figure 5), which negatively affects
the production of pyocyanin (Carty et al. 2006).
Stressful environmental conditions may also be control-
ling the differential expression of the regulatory cas-
cade. For instance, mvfR is involved in regulating critical
physiological processes, being known to control the
transcription of iron-related genes, under low-iron con-
centrations (Ochsner et al. 2002), and upregulating the
transcription of the three QS systems and pyocyanin
Figure 5. Schematic representation of the effect of P. aeruginosa on S. aureus in dual-species biofilms. Annotated interconnec-
tions between the molecules produced by P. aeruginosa, their effect on S. aureus, and the main regulatory network involved in P.
aeruginosa> S. aureus interactions is depicted. Solid arrows: upregulation of gene expression; lines with flat ends: downregulation
of gene expression; dotted arrows: synthesis process; dashed arrows: effect on S. aureus.
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synthesis (Figure 5). Once intracellular iron levels are
high, uptake systems and their regulators, including
mvfR, are repressed by the fur transcriptional regulator
(Troxell and Hassan 2013). This negative feedback loop
also turns down the production of all other systems
under mvfR control (e.g. pyocyanin and HQNO synthe-
sis) (Maura et al. 2016). Under low oxygen or anoxia,
anr controls hydrogen cyanide production and other
cellular responses, including biofilm formation associ-
ated with chronic infections (Hammond et al. 2015).
Targeting P. aeruginosa/S. aureus biofilm
communication
Antivirulence agents are presented as alternative thera-
peutics that can circumvent antibiotic resistance by tar-
geting virulence factors rather than bacterial growth
pathways (i.e. the target of traditional antibiotics)
(Totsika 2016). This strategy is quite advantageous con-
sidering the large number of putative virulent targets
(Allen et al. 2014). Since QS is the main virulence regu-
lator in bacteria, inhibition of QS mechanisms using
quorum quenching (QQ) agents appears to be a prom-
ising strategy to modulate the virulence of bacterial
pathogens (Chan et al. 2015). Moreover, as the target
may constitute an extracellular factor, the emergence
and spread of resistance could be less likely (Fetzner
2015). Nevertheless, the selection of the target is of crit-
ical importance for the effectiveness of the antimicro-
bial strategy. In line with this, it is essential to
understand the full dynamics of action of the targeted
virulence factor as well as the dynamics of production
(Dickey et al. 2017). The expression of certain virulence
factors could be subjected to the control of several
regulatory mechanisms other than the targeted QS sys-
tem (Arya and Princy 2016).
Figure 6 summarizes the antivirulence agents that
have so far shown inhibitory effect against two major
virulence factors produced by P. aeruginosa and anno-
tated as affecting S. aureus in biofilm settings, HQNO
and siderophores (pyoverdine and pyochelin). A search
was made in http://pcquorum.org/ for inhibitors target-
ing not only the molecules of interest but also their
coding genes. A total of 25 and 19 reported agents
were encountered inhibiting HQNO and siderophores,
respectively, with four of them being active against
both pyoverdine and pyochelin (Figure 6).
Although these antivirulence agents may be promis-
ing for attenuating S. aureus and P. aeruginosa resili-
ence in co-infection scenarios, this antivirulence
strategy has to face several challenges to become a
feasible therapeutic option. One of the challenges in
disrupting QS networks is the fact that, in some cases,
the interference with the target could promote viru-
lence instead of attenuating it (Garcıa-Contreras et al.
2015). This point is even more relevant when consider-
ing polymicrobial infections. Because inter-species inter-
actions could be mediate by QS-controlled factors, the
interference with a QS system in a pathogen potentially
could facilitate the pathogenicity of the co-infecting
species (Radlinski et al. 2017). For example, the
PqsABCDE/PqsR system influences the production of
extracellular DNA (Whitchurch et al. 2002) and lectins,
which influences biofilm formation and enhances col-
onisation and infection establishment in P. aeruginosa
(Lee and Zhang 2015). In addition, this system posi-
tively regulates HQNO levels, involved in P. aeruginosa/
S. aureus interactions (Figure 5). Depending on the
environmental conditions found by these pathogens,
different interactions were annotated, including stimu-
lation of S. aureus SCV, antimicrobial protection, and
inhibition of S. aureus growth. Therefore, the interfer-
ence with the QS system could reduce the overall viru-
lence, by inhibiting P. aeruginosa biofilm formation and
possibly preventing the formation of S. aureus SCV. On
the other hand, as HQNO inhibits S. aureus growth, the
antivirulence therapies targeting this molecule could
backfire and facilitate the spreading of S. aureus.
Consequently, the choice of antivirulence agents
must pay attention to the multi-species community as
a whole, that is, the impact on the remaining co-
occurring pathogens must be considered as it can have
a positive, hence undesired, effect on them. Moreover,
to increase antimicrobial effectiveness in polymicrobial
communities, empiric therapy would probably require
the combination with other antimicrobial agents
(including other antivirulence drugs or even antibiotics).
Very few studies have tackled this approach in double-
species biofilms of P. aeruginosa and S. aureus. The only
example found in the literature using an adapted opti-
mized query is the use of the QS inhibitor hamamelitan-
nin targeting the RAP/TRAP QS system in S. aureus,
which was combined with vancomycin in a gauze and
successfully reduced biofilm formation of both species
in an in vitro mixed biofilm model of chronic wound
(Brackman et al. 2016). Although antivirulence
approaches have substantially progressed, it appears
that the search for antivirulence agents is still a chal-
lenging and unexplored area of investigation, with
most of these antivirulence drugs tested in vitro and
against single-species populations (Perez-Perez et al.
2017; Martınez et al. 2019).
Overall, this work was able to decipher the current
knowledge on the complex interactions between P.
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aeruginosa and S. aureus in the context of their com-
petitiveness within the biofilm mode of growth, by
implementing an innovative and systematic analysis of
the scientific literature on this subject. The examination
of the gathered information resulted in the clarification
of the amount and types of studies being conducted,
but more importantly, in the identification of the major
and most studied molecular players in P. aeruginosa/S.
aureus communication and/or interaction. More specif-
ically, with P. aeruginosa revealed as key player,
pseudomonal factors affecting S. aureus were pointed
out (e.g. HQNO and siderophores) and their respective
antivirulence agents identified. Yet, we are still far away
from fully understanding the dynamic and complex net-
works of interactions that occur in the natural infection
environment. Although efforts are being made to
deeply understand the interactions that those microor-
ganisms experience during infection, as this work
shows, the percentage of studies that have pointed out
specific mechanisms of interaction remains relatively
Figure 6. Networks of antivirulence agents targeting (A) the PqsABCDE/PqsR QS system and (B) the siderophores pyoverdine
and pyochelin.
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small. The improvement of more powerful and efficient
genetic tools and the design of feasible in vitro models
that reflect the in vivo environment are pivotal for
exploring unanswered questions about the ecology of
P. aeruginosa/S. aureus biofilm infections. Expectantly,
this work and its resulting database (www.ceb.uminho.
pt/ISCTD.) will assist researchers aiming at diminishing
the resilience of this bacterial consortium within biofilm
related infections by downsizing time and work related
costs.
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